Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Portal hypertension

Nonselective β-blockers in patients with refractory ascites

Nature Reviews Gastroenterology & Hepatology volume 8, pages 10–11 (2011)Cite this article

Subjects

Nonselective β-blockers are often used in patients with cirrhosis and esophageal varices to prevent variceal bleeding. A recent study has suggested that nonselective β-blockers promote more harm than benefit in patients who have cirrhosis and refractory ascites. The authors of the study suggest that these drugs should be contraindicated in these patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lebrec, D., Poynard, T., Hillon, P. & Benhamou, J. P. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. N. Engl. J Med. 305, 1371–1374 (1981).

    Article  CAS  PubMed  Google Scholar 

  2. Poynard, T. et al. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N. Engl. J. Med. 324, 1532–1538 (1991).

    Article  CAS  PubMed  Google Scholar 

  3. Serste, T. et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology 52, 1017–1022 (2010).

    Article  CAS  PubMed  Google Scholar 

  4. Wong, F. & Salerno, F. Beta-blockers in cirrhosis: friend and foe? Hepatology 52, 811–813 (2010).

    Article  PubMed  Google Scholar 

  5. Sharma, P. et al. The haemodynamic response to propranolol in cirrhosis with arterial hypertension: a comparative analysis with normotensive cirrhotic patients. Aliment. Pharmacol. Ther. 32, 105–112 (2010).

    Article  CAS  PubMed  Google Scholar 

  6. Llach, J. et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 94, 482–487 (1988).

    Article  CAS  PubMed  Google Scholar 

  7. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N. Engl. J. Med. 319, 983–989 (1988).

Download references

Author information

Authors and Affiliations

  1. Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut de IDIBAPS and CIBERehd, Villaroel 170, 08036, Barcelona, Spain

    Juan Carlos Garcia-Pagán

Authors
  1. Juan Carlos Garcia-Pagán
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garcia-Pagán, J. Nonselective β-blockers in patients with refractory ascites. Nat Rev Gastroenterol Hepatol 8, 10–11 (2011). https://doi.org/10.1038/nrgastro.2010.185

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2010.185

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing